Amarin (AMRN) Vascepa Exclusivity Status Not in FDA Orange Book March Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to Amarin (AMRN) Vascepa Exclusivity Status Not in FDA Orange Book March Update

Amarin's (AMRN) Vascepa Not in FDA Orange Book for April

May 17, 2013 2:32 PM EDT

Amarin (Nasdaq: AMRN) is rebounding following an earlier dip on news that its Vascepa wasn't in the FDA Orange Book for April.

To go to the FDA's Orange Book website, click here.

Shares are down 0.5 percent Friday.... More